Handelsavisen
prelaunch
Companies Healthcare 0125.HK
01
0125.HK HKEX Medical Equipment, Supplies & Distribution

Sun Hing Vision Group Holdings Ltd

HK$0,30
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Sun Hing Vision Group Holdings Ltd operates in the healthcare services and equipment industry, focusing on medical equipment, supplies, and distribution.

Business. Sun Hing Vision Group Holdings Ltd (0125.HK) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. It is listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 0125.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 0125.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Sun Hing Vision Group Holdings Ltd (0125.HK) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related consumables. It is listed on the Hong Kong Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Sun Hing Vision Group Holdings Ltd has a basic and diluted share count of 262,778,286, indicating no immediate dilution pressure from share issuance. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.

    The company's profitability and return metrics are not available in the current dataset, making it difficult to compare its performance against industry benchmarks or preferred metrics for the healthcare services and equipment sector. Without these metrics, an assessment of its operational efficiency and financial health is constrained.

    Segment and geographic exposure details are not disclosed in the available data, limiting the ability to evaluate revenue concentration or geographic diversification. This lack of information hinders a comprehensive understanding of the company's risk profile and market positioning.

    Growth trajectory data is also not available, preventing an analysis of the company's revenue history or future outlook. Without forward-looking guidance or historical performance, it is challenging to assess the company's potential for expansion or contraction.

    Risk factors include the inability to assess liquidity risk, which could affect the company's ability to meet short-term obligations. The dilution risk is currently low, but the absence of valuation adjustments or liquidity metrics means that future dilution potential cannot be ruled out.

    Recent events, including filings and transcripts, are not disclosed in the available data, which limits the ability to evaluate the company's recent strategic moves or operational developments.

    Key takeaways
    • The company has no immediate dilution pressure based on current share counts.
    • Liquidity risk cannot be assessed due to missing balance-sheet data and lack of going-concern language.
    • Profitability and return metrics are not available, limiting performance benchmarking.
    • Segment and geographic exposure details are not disclosed, making it difficult to evaluate diversification.
    • Growth trajectory and future outlook data are not available, hindering expansion potential analysis.
    • Recent strategic or operational developments are not disclosed in the available data.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2012-06-22
    FY 2012 · Full-year highlights

    Revenue HK$702.3M, −0,4% YoY; Operating income −7,2% YoY.

    RevenueHK$702.3M−0,4 % YoY
    Operating income-HK$35.1M−7,2 % YoY
    Net income-HK$28.4M+7,2 % YoY
    Free cash flow-HK$22.5M−24,1 % YoY
    EPS
    Operating cash flow-HK$25.8M−177,1 % YoY
    Financials
    Income statement
    RevenueHK$702.3M
    Gross profitHK$74.9M
    Operating income-HK$35.1M
    Net income-HK$28.4M
    Margins
    Gross margin10.7%
    Operating margin-5.0%
    Net margin-4.0%
    FCF margin-3.2%
    Balance sheet
    Total assetsHK$906.0M
    Total liabilitiesHK$235.6M
    Total equityHK$670.4M
    Cash & equivalentsHK$274.5M
    Long-term debtHK$53.1M
    Cash flow
    Operating cash flow-HK$25.8M
    CapEx-HK$11.3M
    Free cash flow-HK$22.5M
    SBC
    P&L flow · revenue → net income
    Revenue HK$702.3MOperating costs HK$737.4MNet income HK$28.4M
    Highlights
    • Revenue HK$702.3M, −0,4% YoY
    • Operating income −7,2% YoY
    • Net income +7,2% YoY
    • Free cash flow −24,1% YoY
    • Net margin -4.0%

    Valuation FY

    Market price
    HK$0,30
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Sun Hing Vision Group Holdings Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    0125.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2012-06-22 18:59 UTCEARNINGSAnnual results — FY 2012 Revenue HKD 702.3M · Net HKD -28.4M
    2009-07-10 18:41 UTCEARNINGSAnnual results — FY 2009 Revenue HKD 701.7M · Net HKD 9.6M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage